Skip to content

Tandem Diabetes Care TNDM Operating Income

Operating Income at other companies

Insulet logo
InsuletPODD
$122.1M+37.5%
Medtronic logo
MedtronicMDT
$1.87B+30.4%
AdaptHealth logo
AdaptHealthAHCO
$5.49M-76.3%
Mannkind logo
MannkindMNKD
-$1.67M-107%
Abbott logo
AbbottABT
$1.35B-20.6%
Omnicell logo
OmnicellOMCL
$16.85M+245%

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-23.6%
Enterprise value$1.58B-11.3%
P/S-0.4×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's operating income?
Tandem Diabetes Care (TNDM) reported operating income of -$17.43M in Q1 2026.
How has Tandem Diabetes Care's operating income changed year-over-year?
Tandem Diabetes Care's operating income increased by 85.6% year-over-year, from -$120.88M to -$17.43M.
What is the long-term trend for Tandem Diabetes Care's operating income?
Over 4 years (2021 to 2025), Tandem Diabetes Care's operating income has grown at a 69.6% compound annual growth rate (CAGR), from $22.65M to -$187.26M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.